{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:41:52Z","timestamp":1783960912645,"version":"3.55.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,6]]},"DOI":"10.7759\/cureus.96208","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:39:00Z","timestamp":1762432740000},"source":"Crossref","is-referenced-by-count":1,"title":["Bisphosphonate-Related Atypical Femoral Fractures: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Fuad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdelazim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Elasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakar","family":"Bhamidipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-021-02821-8","article-title":"Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis","volume":"16","author":"Salari N","year":"2021","unstructured":"Salari N, Darvishi N, Bartina Y, et al.. Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021, 16:669. 10.1186\/s13018-021-02821-8","journal-title":"J Orthop Surg Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2024.101750","article-title":"The multi-faceted nature of age-associated osteoporosis","volume":"20","author":"Smit AE","year":"2024","unstructured":"Smit AE, Meijer OC, Winter EM. The multi-faceted nature of age-associated osteoporosis. Bone Rep. 2024, 20:101750. 10.1016\/j.bonr.2024.101750","journal-title":"Bone Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-011-1164-9","article-title":"Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies","volume":"40","author":"Reid IR","year":"2011","unstructured":"Reid IR. Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies. Skeletal Radiol. 2011, 40:1191-6. 10.1007\/s00256-011-1164-9","journal-title":"Skeletal Radiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake MT","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008, 83:1032-45. 10.4065\/83.9.1032","journal-title":"Mayo Clin Proc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-003-0622-z","article-title":"Bisphosphonates in osteoporosis","volume":"12","author":"Fleisch H","year":"2003","unstructured":"Fleisch H. Bisphosphonates in osteoporosis. Eur Spine J. 2003, 12:S142-6. 10.1007\/s00586-003-0622-z","journal-title":"Eur Spine J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001086","article-title":"Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur","volume":"362","author":"Black DM","year":"2010","unstructured":"Black DM, Kelly MP, Genant HK, et al.. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010, 362:1761-71. 10.1056\/NEJMoa1001086","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.20945\/2359-4292-2022-0334","article-title":"Long-term consequences of osteoporosis therapy with bisphosphonates","volume":"68","author":"Gehrke B","year":"2023","unstructured":"Gehrke B, Alves Coelho MC, Brasil d'Alva C, Madeira M. Long-term consequences of osteoporosis therapy with bisphosphonates. Arch Endocrinol Metab. 2023, 68:e220334. 10.20945\/2359-4292-2022-0334","journal-title":"Arch Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black DM","year":"2020","unstructured":"Black DM, Geiger EJ, Eastell R, et al.. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med. 2020, 383:743-53. 10.1056\/NEJMoa1916525","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S149236","article-title":"Minodronate for the treatment of osteoporosis","volume":"14","author":"Ohishi T","year":"2018","unstructured":"Ohishi T, Matsuyama Y. Minodronate for the treatment of osteoporosis. Ther Clin Risk Manag. 2018, 14:729-39. 10.2147\/TCRM.S149236","journal-title":"Ther Clin Risk Manag"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/M22-0684","article-title":"Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American College of Physicians","volume":"176","author":"Ayers C","year":"2023","unstructured":"Ayers C, Kansagara D, Lazur B, Fu R, Kwon A, Harrod C. Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American College of Physicians. Ann Intern Med. 2023, 176:182-95. 10.7326\/M22-0684","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X11416270","article-title":"Atypical femur fractures: a review of the evidence and its implication to clinical practice","volume":"3","author":"Girgis CM","year":"2011","unstructured":"Girgis CM, Seibel MJ. Atypical femur fractures: a review of the evidence and its implication to clinical practice. Ther Adv Musculoskelet Dis. 2011, 3:301-14. 10.1177\/1759720X11416270","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1302\/2058-5241.3.170070","article-title":"The enigma of atypical femoral fractures: a summary of current knowledge","volume":"3","author":"Larsen MS","year":"2018","unstructured":"Larsen MS, Schmal H. The enigma of atypical femoral fractures: a summary of current knowledge. EFORT Open Rev. 2018, 3:494-500. 10.1302\/2058-5241.3.170070","journal-title":"EFORT Open Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000041513","article-title":"Etiological, clinical characteristics, and treatment of atypical femur fracture: a retrospective study","volume":"104","author":"Wang H","year":"2025","unstructured":"Wang H, Zhang Z, Zhou F, Song C, Yang Z, Hou G, Tian Y. Etiological, clinical characteristics, and treatment of atypical femur fracture: a retrospective study. Medicine (Baltimore). 2025, 104:e41513. 10.1097\/MD.0000000000041513","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2024.111346","article-title":"Prevalence of atypical femoral fractures, a clinical update: a comparative retrospective study 7 years later","volume":"55","author":"Bottai V","year":"2024","unstructured":"Bottai V, Antognetti D, Troiano E, et al.. Prevalence of atypical femoral fractures, a clinical update: a comparative retrospective study 7 years later. Injury. 2024, 55:111346. 10.1016\/j.injury.2024.111346","journal-title":"Injury"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane E","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR, et al.. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010, 25:2267-94. 10.1002\/jbmr.253","journal-title":"J Bone Miner Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-014-9908-x","article-title":"Identifying atypical femoral fractures--a retrospective review","volume":"95","author":"Juby AG","year":"2014","unstructured":"Juby AG, Crowther S, Cree M. Identifying atypical femoral fractures--a retrospective review. Calcif Tissue Int. 2014, 95:405-12. 10.1007\/s00223-014-9908-x","journal-title":"Calcif Tissue Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmbbm.2021.104803","article-title":"Biomechanical mechanisms of atypical femoral fracture","volume":"124","author":"Ural A","year":"2021","unstructured":"Ural A. Biomechanical mechanisms of atypical femoral fracture. J Mech Behav Biomed Mater. 2021, 124:104803. 10.1016\/j.jmbbm.2021.104803","journal-title":"J Mech Behav Biomed Mater"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnha.2024.100357","article-title":"Characteristics of fragility hip fracture-related falls in the older adults: a systematic review","volume":"28","author":"Lim SK","year":"2024","unstructured":"Lim SK, Choi K, Heo NH, Kim Y, Lim JY. Characteristics of fragility hip fracture-related falls in the older adults: a systematic review. J Nutr Health Aging. 2024, 28:100357. 10.1016\/j.jnha.2024.100357","journal-title":"J Nutr Health Aging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.6262","article-title":"Bisphosphonate-related complete atypical subtrochanteric femoral fractures: diagnostic utility of radiography","volume":"197","author":"Rosenberg ZS","year":"2011","unstructured":"Rosenberg ZS, La Rocca Vieira R, Chan SS, et al.. Bisphosphonate-related complete atypical subtrochanteric femoral fractures: diagnostic utility of radiography. AJR Am J Roentgenol. 2011, 197:954-60. 10.2214\/AJR.10.6262","journal-title":"AJR Am J Roentgenol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/99102700","article-title":"Skeletal complications of bisphosphonate use: what the radiologist should know","volume":"85","author":"Haworth AE","year":"2012","unstructured":"Haworth AE, Webb J. Skeletal complications of bisphosphonate use: what the radiologist should know. Br J Radiol. 2012, 85:1333-42. 10.1259\/bjr\/99102700","journal-title":"Br J Radiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1392-9","article-title":"Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study","volume":"18","author":"Eisenstein N","year":"2017","unstructured":"Eisenstein N, Kasavkar G, Bhavsar D, Khan FS, Paskins Z. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study. BMC Musculoskelet Disord. 2017, 18:29. 10.1186\/s12891-017-1392-9","journal-title":"BMC Musculoskelet Disord"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2016.06.029","article-title":"Atypical femoral fractures and current management","volume":"7","author":"Zheng N","year":"2016","unstructured":"Zheng N, Tang N, Qin L. Atypical femoral fractures and current management. J Orthop Translat. 2016, 7:7-22. 10.1016\/j.jot.2016.06.029","journal-title":"J Orthop Translat"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-sat-540","article-title":"SAT-540 bisphosphonates and fracture incidence in young adults","volume":"3","author":"Choudhary M","year":"2019","unstructured":"Choudhary M, Chock B. SAT-540 bisphosphonates and fracture incidence in young adults. J Endocr Soc. 2019, 3:540. 10.1210\/js.2019-sat-540","journal-title":"J Endocr Soc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03672-w","article-title":"Risk of complete atypical femur fracture with oral bisphosphonate exposure beyond three years","volume":"21","author":"Lo JC","year":"2020","unstructured":"Lo JC, Neugebauer RS, Ettinger B, et al.. Risk of complete atypical femur fracture with oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 2020, 21:801. 10.1186\/s12891-020-03672-w","journal-title":"BMC Musculoskelet Disord"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3109\/17453674.2015.1004149","article-title":"Risk of atypical femoral fracture during and after bisphosphonate use","volume":"86","author":"Schilcher J","year":"2015","unstructured":"Schilcher J, Koeppen V, Aspenberg P, Micha\u00eblsson K. Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop. 2015, 86:100-7. 10.3109\/17453674.2015.1004149","journal-title":"Acta Orthop"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz295","article-title":"Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society","volume":"105","author":"van de Laarschot DM","year":"2020","unstructured":"van de Laarschot DM, McKenna MJ, Abrahamsen B, et al.. Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society. J Clin Endocrinol Metab. 2020, 105:1682-99. 10.1210\/clinem\/dgz295","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10607","article-title":"Asian ethnicity and femoral geometry in atypical femur fractures: independent or interdependent risk factors?","volume":"6","author":"Dhanekula ND","year":"2022","unstructured":"Dhanekula ND, Crouch G, Byth K, et al.. Asian ethnicity and femoral geometry in atypical femur fractures: independent or interdependent risk factors?. JBMR Plus. 2022, 6:e10607. 10.1002\/jbm4.10607","journal-title":"JBMR Plus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07654-3","article-title":"Femur geometry influences atypical femoral fracture location","volume":"2025","author":"Bruce OL","year":"2025","unstructured":"Bruce OL, Haider IT, Cheung AM, Tile L, Bleakney R, Scher J, Edwards WB. Femur geometry influences atypical femoral fracture location. Osteoporos Int. 2025, 2025:s00198. 10.1007\/s00198-025-07654-3","journal-title":"Osteoporos Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2174\/1568010054022015","article-title":"Osteoblasts and osteoclasts in bone remodeling and inflammation","volume":"4","author":"Tanaka Y","year":"2005","unstructured":"Tanaka Y, Nakayamada S, Okada Y. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy. 2005, 4:325-8. 10.2174\/1568010054022015","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2016.03.007","article-title":"The role of osteoblasts in bone metastasis","volume":"5","author":"Ottewell PD","year":"2016","unstructured":"Ottewell PD. The role of osteoblasts in bone metastasis. J Bone Oncol. 2016, 5:124-7. 10.1016\/j.jbo.2016.03.007","journal-title":"J Bone Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2022.101646","article-title":"Tuning the resorption-formation balance in an in vitro 3D osteoblast-osteoclast co-culture model of bone","volume":"18","author":"Remmers SJ","year":"2023","unstructured":"Remmers SJ, van der Heijden FC, de Wildt BW, Ito K, Hofmann S. Tuning the resorption-formation balance in an in vitro 3D osteoblast-osteoclast co-culture model of bone. Bone Rep. 2023, 18:101646. 10.1016\/j.bonr.2022.101646","journal-title":"Bone Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.17179\/excli2020-2591","article-title":"Osteoporosis: pathophysiology and therapeutic options","volume":"19","author":"F\u00f6ger-Samwald U","year":"2020","unstructured":"F\u00f6ger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K, Pietschmann P. Osteoporosis: pathophysiology and therapeutic options. EXCLI J. 2020, 19:1017-37. 10.17179\/excli2020-2591","journal-title":"EXCLI J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.91","article-title":"Physiological and pathophysiological bone turnover - role of the immune system","volume":"12","author":"Weitzmann MN","year":"2016","unstructured":"Weitzmann MN, Ofotokun I. Physiological and pathophysiological bone turnover - role of the immune system. Nat Rev Endocrinol. 2016, 12:518-32. 10.1038\/nrendo.2016.91","journal-title":"Nat Rev Endocrinol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00371-3","article-title":"Osteoporosis pathogenesis and treatment: existing and emerging avenues","volume":"27","author":"Liang B","year":"2022","unstructured":"Liang B, Burley G, Lin S, Shi YC. Osteoporosis pathogenesis and treatment: existing and emerging avenues. Cell Mol Biol Lett. 2022, 27:72. 10.1186\/s11658-022-00371-3","journal-title":"Cell Mol Biol Lett"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5855","article-title":"Bone remodelling in humans is load-driven but not lazy","volume":"5","author":"Christen P","year":"2014","unstructured":"Christen P, Ito K, Ellouz R, Boutroy S, Sornay-Rendu E, Chapurlat RD, van Rietbergen B. Bone remodelling in humans is load-driven but not lazy. Nat Commun. 2014, 5:4855. 10.1038\/ncomms5855","journal-title":"Nat Commun"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-014-0371-z","article-title":"Stress fracture of the pelvis and lower limbs including atypical femoral fractures-a review","volume":"6","author":"Tins BJ","year":"2015","unstructured":"Tins BJ, Garton M, Cassar-Pullicino VN, Tyrrell PN, Lalam R, Singh J. Stress fracture of the pelvis and lower limbs including atypical femoral fractures-a review. Insights Imaging. 2015, 6:97-110. 10.1007\/s13244-014-0371-z","journal-title":"Insights Imaging"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20201457","article-title":"Atraumatic fractures of the femur","volume":"94","author":"Hedge G","year":"2021","unstructured":"Hedge G, Thaker S, Botchu R, Fawcett R, Gupta H. Atraumatic fractures of the femur. Br J Radiol. 2021, 94:20201457. 10.1259\/bjr.20201457","journal-title":"Br J Radiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiomech.2014.08.001","article-title":"Femoral shaft strains during daily activities: implications for atypical femoral fractures","volume":"29","author":"Martelli S","year":"2014","unstructured":"Martelli S, Pivonka P, Ebeling PR. Femoral shaft strains during daily activities: implications for atypical femoral fractures. Clin Biomech (Bristol). 2014, 29:869-76. 10.1016\/j.clinbiomech.2014.08.001","journal-title":"Clin Biomech (Bristol)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/srep43399","article-title":"Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties","volume":"7","author":"Ma S","year":"2017","unstructured":"Ma S, Goh EL, Jin A, et al.. Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties. Sci Rep. 2017, 7:43399. 10.1038\/srep43399","journal-title":"Sci Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s002230010036","article-title":"Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage","volume":"69","author":"Li J","year":"2001","unstructured":"Li J, Mashiba T, Burr DB. Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage. Calcif Tissue Int. 2001, 69:281-6. 10.1007\/s002230010036","journal-title":"Calcif Tissue Int"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2015.11","article-title":"Bone microdamage, remodeling and bone fragility: how much damage is too much damage?","volume":"4","author":"Seref-Ferlengez Z","year":"2015","unstructured":"Seref-Ferlengez Z, Kennedy OD, Schaffler MB. Bone microdamage, remodeling and bone fragility: how much damage is too much damage?. Bonekey Rep. 2015, 4:644. 10.1038\/bonekey.2015.11","journal-title":"Bonekey Rep"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1302\/2046-3758.610.BJR-2016-0321.R1","article-title":"The effect of long-term bisphosphonate therapy on trabecular bone strength and microcrack density","volume":"6","author":"Jin A","year":"2017","unstructured":"Jin A, Cobb J, Hansen U, et al.. The effect of long-term bisphosphonate therapy on trabecular bone strength and microcrack density. Bone Joint Res. 2017, 6:602-9. 10.1302\/2046-3758.610.BJR-2016-0321.R1","journal-title":"Bone Joint Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-018-0430-3","article-title":"Recent advances in understanding bisphosphonate effects on bone mechanical properties","volume":"16","author":"Allen MR","year":"2018","unstructured":"Allen MR. Recent advances in understanding bisphosphonate effects on bone mechanical properties. Curr Osteoporos Rep. 2018, 16:198-204. 10.1007\/s11914-018-0430-3","journal-title":"Curr Osteoporos Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2014.24","article-title":"Bisphosphonates and bone quality","volume":"3","author":"Pazianas M","year":"2014","unstructured":"Pazianas M, van der Geest S, Miller P. Bisphosphonates and bone quality. Bonekey Rep. 2014, 3:529. 10.1038\/bonekey.2014.24","journal-title":"Bonekey Rep"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160450","article-title":"Atypical femoral fracture","volume":"189","author":"Khan AA","year":"2017","unstructured":"Khan AA, Kaiser S. Atypical femoral fracture. CMAJ. 2017, 189:E542. 10.1503\/cmaj.160450","journal-title":"CMAJ"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-022-05990-7","article-title":"Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: a case report","volume":"23","author":"Tsuchiya K","year":"2022","unstructured":"Tsuchiya K, Okano I, Shiose K, et al.. Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: a case report. BMC Musculoskelet Disord. 2022, 23:1103. 10.1186\/s12891-022-05990-7","journal-title":"BMC Musculoskelet Disord"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.artd.2016.02.004","article-title":"Bilateral atypical femoral fracture and end-stage arthritis of the hip, treated with total hip arthroplasty","volume":"2","author":"Sandilands SM","year":"2016","unstructured":"Sandilands SM, Villa JM, Lavernia CJ. Bilateral atypical femoral fracture and end-stage arthritis of the hip, treated with total hip arthroplasty. Arthroplast Today. 2016, 2:147-52. 10.1016\/j.artd.2016.02.004","journal-title":"Arthroplast Today"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8824756","article-title":"Clinical features and outcomes of bilateral atypical femoral fractures","volume":"2020","author":"Hamahashi K","year":"2020","unstructured":"Hamahashi K, Noguchi T, Uchiyama Y, Sato M, Watanabe M. Clinical features and outcomes of bilateral atypical femoral fractures. Case Rep Orthop. 2020, 2020:8824756. 10.1155\/2020\/8824756","journal-title":"Case Rep Orthop"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2021.101112","article-title":"Bilateral atypical fractures of the femur: ten years AFTER ten years of bisphosphonate therapy","volume":"15","author":"Smith MD","year":"2021","unstructured":"Smith MD, Haseman OJ, Velez Garza JA, Bruder JM. Bilateral atypical fractures of the femur: ten years AFTER ten years of bisphosphonate therapy. Bone Rep. 2021, 15:101112. 10.1016\/j.bonr.2021.101112","journal-title":"Bone Rep"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12031038","article-title":"Bilateral atypical femoral fractures after bisphosphonate treatment for osteoporosis: a literature review","volume":"12","author":"Hwang S","year":"2023","unstructured":"Hwang S, Seo M, Lim D, Choi MS, Park JW, Nam K. Bilateral atypical femoral fractures after bisphosphonate treatment for osteoporosis: a literature review. J Clin Med. 2023, 12:1038. 10.3390\/jcm12031038","journal-title":"J Clin Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10259","article-title":"Atypical femur fractures in patients treated with bisphosphonates: identification, management, and prevention","volume":"7","author":"Bubbear JS","year":"2016","unstructured":"Bubbear JS. Atypical femur fractures in patients treated with bisphosphonates: identification, management, and prevention. Rambam Maimonides Med J. 2016, 7:e0032. 10.5041\/RMMJ.10259","journal-title":"Rambam Maimonides Med J"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.6745","article-title":"Time to benefit of bisphosphonate therapy for the prevention of fractures among postmenopausal women with osteoporosis: a meta-analysis of randomized clinical trials","volume":"182","author":"Deardorff WJ","year":"2022","unstructured":"Deardorff WJ, Cenzer I, Nguyen B, Lee SJ. Time to benefit of bisphosphonate therapy for the prevention of fractures among postmenopausal women with osteoporosis: a meta-analysis of randomized clinical trials. JAMA Intern Med. 2022, 182:33-41. 10.1001\/jamainternmed.2021.6745","journal-title":"JAMA Intern Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7442","article-title":"Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy","volume":"198","author":"La Rocca Vieira R","year":"2012","unstructured":"La Rocca Vieira R, Rosenberg ZS, Allison MB, Im SA, Babb J, Peck V. Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy. AJR Am J Roentgenol. 2012, 198:1144-51. 10.2214\/AJR.11.7442","journal-title":"AJR Am J Roentgenol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e157","article-title":"Low positive predictive value of bone scan to predict impending complete fracture among incomplete atypical femoral fracture","volume":"33","author":"Lee YK","year":"2018","unstructured":"Lee YK, Lee YJ, Lee NK, Nho JH, Koo KH. Low positive predictive value of bone scan to predict impending complete fracture among incomplete atypical femoral fracture. J Korean Med Sci. 2018, 33:e157. 10.3346\/jkms.2018.33.e157","journal-title":"J Korean Med Sci"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.20.00807","article-title":"Progression of asymptomatic contralateral femur in patients with complete atypical femoral fracture, according to initial radiographic findings","volume":"103","author":"Lee KJ","year":"2021","unstructured":"Lee KJ, Min BW, Bae KC, Cho CH, Lee SW, Kim BS. Progression of asymptomatic contralateral femur in patients with complete atypical femoral fracture, according to initial radiographic findings. J Bone Joint Surg Am. 2021, 103:123-30. 10.2106\/JBJS.20.00807","journal-title":"J Bone Joint Surg Am"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2017.01.002","article-title":"A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate","volume":"6","author":"Nguyen HH","year":"2017","unstructured":"Nguyen HH, Milat F, Ebeling PR. A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate. Bone Rep. 2017, 6:34-7. 10.1016\/j.bonr.2017.01.002","journal-title":"Bone Rep"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37560-9","article-title":"Detection of incomplete atypical femoral fracture on anteroposterior radiographs via explainable artificial intelligence","volume":"13","author":"Kim T","year":"2023","unstructured":"Kim T, Moon NH, Goh TS, Jung ID. Detection of incomplete atypical femoral fracture on anteroposterior radiographs via explainable artificial intelligence. Sci Rep. 2023, 13:10415. 10.1038\/s41598-023-37560-9","journal-title":"Sci Rep"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22725","article-title":"Incomplete atypical femoral fracture treated by prophylactic intramedullary nail fixation: a case series","volume":"14","author":"Sakuda T","year":"2022","unstructured":"Sakuda T, Omoto O, Hamasaki T, Okimoto N, Adachi N. Incomplete atypical femoral fracture treated by prophylactic intramedullary nail fixation: a case series. Cureus. 2022, 14:e22725. 10.7759\/cureus.22725","journal-title":"Cureus"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20916983","article-title":"Atypical femur fractures: current understanding and approach to management","volume":"12","author":"Tile L","year":"2020","unstructured":"Tile L, Cheung AM. Atypical femur fractures: current understanding and approach to management. Ther Adv Musculoskelet Dis. 2020, 12:6983. 10.1177\/1759720X20916983","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-05067-7","article-title":"Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up","volume":"30","author":"Png MA","year":"2019","unstructured":"Png MA, Mohan PC, Koh JS, Howe CY, Howe TS. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up. Osteoporos Int. 2019, 30:2417-28. 10.1007\/s00198-019-05067-7","journal-title":"Osteoporos Int"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-022-01378-8","article-title":"Factors affecting healing and progression of conservatively treated incomplete atypical femoral fractures: retrospective observational study","volume":"41","author":"Png MA","year":"2023","unstructured":"Png MA, Koh JS, Mohan PC, Howe CY, Howe TS. Factors affecting healing and progression of conservatively treated incomplete atypical femoral fractures: retrospective observational study. J Bone Miner Metab. 2023, 41:61-73. 10.1007\/s00774-022-01378-8","journal-title":"J Bone Miner Metab"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v14.i5.302","article-title":"Surgical strategy of the treatment of atypical femoral fractures","volume":"14","author":"Shim BJ","year":"2023","unstructured":"Shim BJ, Won H, Kim SY, Baek SH. Surgical strategy of the treatment of atypical femoral fractures. World J Orthop. 2023, 14:302-11. 10.5312\/wjo.v14.i5.302","journal-title":"World J Orthop"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.99B3.BJJ-2016-0276.R2","article-title":"Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management","volume":"99","author":"Koh A","year":"2017","unstructured":"Koh A, Guerado E, Giannoudis PV. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management. Bone Joint J. 2017, 99:295-302. 10.1302\/0301-620X.99B3.BJJ-2016-0276.R2","journal-title":"Bone Joint J"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.oto.2023.101039","article-title":"Special considerations in management of atypical femur fractures","volume":"33","author":"Melvin PR","year":"2023","unstructured":"Melvin PR, Perdue P. Special considerations in management of atypical femur fractures. Oper\u202fTech\u202fOrthop. 2023, 33:101039. 10.1016\/j.oto.2023.101039","journal-title":"Oper\u202fTech\u202fOrthop"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.4235\/agmr.19.0046","article-title":"Management challenges in atypical femoral fractures: a case report","volume":"24","author":"Golsorkhtabaramiri M","year":"2020","unstructured":"Golsorkhtabaramiri M, Inderjeeth CA. Management challenges in atypical femoral fractures: a case report. Ann Geriatr Med Res. 2020, 24:50-4. 10.4235\/agmr.19.0046","journal-title":"Ann Geriatr Med Res"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-16-00717","article-title":"Surgical management of atypical femur fractures associated with bisphosphonate therapy","volume":"26","author":"Githens M","year":"2018","unstructured":"Githens M, Garner MR, Firoozabadi R. Surgical management of atypical femur fractures associated with bisphosphonate therapy. J Am Acad Orthop Surg. 2018, 26:864-71. 10.5435\/JAAOS-D-16-00717","journal-title":"J Am Acad Orthop Surg"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.2490\/prm.20200007","article-title":"Post-operative rehabilitation of atypical femoral fracture in a single center","volume":"5","author":"Mizutani Y","year":"2020","unstructured":"Mizutani Y, Horiuchi H, Nakamura Y, et al.. Post-operative rehabilitation of atypical femoral fracture in a single center. Prog Rehabil Med. 2020, 5:20200007. 10.2490\/prm.20200007","journal-title":"Prog Rehabil Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051140","article-title":"Duration of bisphosphonate drug holidays in osteoporosis patients: a narrative review of the evidence and considerations for decision-making","volume":"10","author":"Hayes KN","year":"2021","unstructured":"Hayes KN, Winter EM, Cadarette SM, Burden AM. Duration of bisphosphonate drug holidays in osteoporosis patients: a narrative review of the evidence and considerations for decision-making. J Clin Med. 2021, 10:1140. 10.3390\/jcm10051140","journal-title":"J Clin Med"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000566","article-title":"Anabolic therapy for osteoporosis: update on efficacy and safety","volume":"66","author":"Bandeira L","year":"2022","unstructured":"Bandeira L, Lewiecki EM. Anabolic therapy for osteoporosis: update on efficacy and safety. Arch Endocrinol Metab. 2022, 66:707-16. 10.20945\/2359-3997000000566","journal-title":"Arch Endocrinol Metab"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jor.2016.07.007","article-title":"Simultaneous, bilateral, complete atypical femoral fractures after long-term alendronate use","volume":"13","author":"Higgins M","year":"2016","unstructured":"Higgins M, Morgan-John S, Badhe S. Simultaneous, bilateral, complete atypical femoral fractures after long-term alendronate use. J Orthop. 2016, 13:401-3. 10.1016\/j.jor.2016.07.007","journal-title":"J Orthop"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/427268-bisphosphonate-related-atypical-femoral-fractures-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:39:01Z","timestamp":1762432741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/427268-bisphosphonate-related-atypical-femoral-fractures-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":70,"URL":"https:\/\/doi.org\/10.7759\/cureus.96208","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}